春立医疗
(688236)
| 流通市值：49.90亿 | | | 总市值：66.36亿 |
| 流通股本：2.88亿 | | | 总股本：3.84亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 216,972,373.23 | 1,045,766,405.34 | 756,093,897.4 | 487,596,405.66 |
| 营业收入 | 216,972,373.23 | 1,045,766,405.34 | 756,093,897.4 | 487,596,405.66 |
| 二、营业总成本 | 152,107,504.3 | 722,853,785.21 | 515,865,735.32 | 333,777,775.81 |
| 营业成本 | 73,197,939.64 | 355,128,323.72 | 247,450,780.09 | 160,472,617.89 |
| 税金及附加 | 2,618,875.54 | 10,178,302.28 | 6,867,479.82 | 4,531,943.83 |
| 销售费用 | 39,159,180.28 | 198,182,667.23 | 146,195,182.01 | 96,267,759.62 |
| 管理费用 | 11,140,244.15 | 52,257,644.14 | 38,603,081.68 | 28,394,457.44 |
| 研发费用 | 26,538,690.18 | 118,503,200.2 | 86,472,598.27 | 50,854,271.53 |
| 财务费用 | -547,425.49 | -11,396,352.36 | -9,723,386.55 | -6,743,274.5 |
| 其中:利息费用 | - | 39,150.21 | 14,188.8 | 12,292.7 |
| 其中:利息收入 | 3,599,755.52 | 15,278,391.56 | 10,658,846.31 | 7,674,348.71 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,337,534.25 | 8,742,663 | 7,078,936.97 | 4,296,252.04 |
| 加:投资收益 | - | 6,315,413.45 | 3,217,026.86 | 3,217,026.86 |
| 资产处置收益 | - | 3,848.03 | 3,848.03 | 3,848.03 |
| 资产减值损失(新) | -1,192,598.77 | -37,239,267.09 | -32,062,823.41 | -26,911,765.98 |
| 信用减值损失(新) | -248,050.73 | -9,700,984.89 | -13,646,674.5 | -12,418,491.12 |
| 其他收益 | 2,286,983.35 | 11,210,787.3 | 6,909,455.54 | 5,307,719.73 |
| 四、营业利润 | 68,048,737.03 | 302,245,079.93 | 211,727,931.57 | 127,313,219.41 |
| 加:营业外收入 | 1,967.79 | 204,535.55 | 195,880.52 | 0.84 |
| 减:营业外支出 | 36,134.02 | 737,901.89 | 135,115.14 | 700 |
| 五、利润总额 | 68,014,570.8 | 301,711,713.59 | 211,788,696.95 | 127,312,520.25 |
| 减:所得税费用 | 6,333,487.03 | 29,086,594.22 | 20,176,273.09 | 12,831,365.21 |
| 六、净利润 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 | 114,481,155.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 | 114,481,155.04 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 61,710,990.86 | 272,542,347.59 | 191,531,404.47 | 114,469,490.87 |
| 少数股东损益 | -29,907.09 | 82,771.78 | 81,019.39 | 11,664.17 |
| 扣除非经常损益后的净利润 | 58,869,012.49 | 255,525,502.91 | 180,704,056.22 | 106,185,458.23 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.71 | 0.5 | 0.3 |
| (二)稀释每股收益 | 0.16 | 0.71 | 0.5 | 0.3 |
| 九、综合收益总额 | 61,681,083.77 | 272,625,119.37 | 191,612,423.86 | 114,481,155.04 |
| 归属于母公司股东的综合收益总额 | 61,710,990.86 | 272,542,347.59 | 191,531,404.47 | 114,469,490.87 |
| 归属于少数股东的综合收益总额 | -29,907.09 | 82,771.78 | 81,019.39 | 11,664.17 |
| 公告日期 | 2026-04-30 | 2026-03-31 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |